vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT)

CUSIP: 918385204

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding
4,080,222
Total 13F shares
348,140
Share change
+14,490
Total reported value
$6,148,038
Price per share
$17.66
Number of holders
19
Value change
+$252,272
Number of buys
8
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 918385204?
CUSIP 918385204 identifies VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) as of Q2 2024

As of 30 Jun 2024, vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 348,140 shares. The largest 10 holders included Samsara BioCapital, LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, UBS Group AG, BlackRock Inc., MORGAN STANLEY, Planning Capital Management Corp, Strengthening Families & Communities, LLC, and OSAIC HOLDINGS, INC.. This page lists 19 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.